Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,064.01
(
0.00%
)
US TECH 100
25,987.14
(
0.83%
)
Dow Jones
49,447.43
(
0.00%
)
Brent Oil
95.64
(
0.66%
)
Bitcoin
78,274.13
(
2.55%
)
News Focus
News Focus
Post# of 10023
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Flair09

Send PM Follow Ignore
Followers 5
Posts 1157
Boards Moderated 0
Alias Born 09/13/2017

Flair09

Re: AntonChigurh post# 5389

Saturday, 02/24/2018 6:11:54 PM

Saturday, February 24, 2018 6:11:54 PM

Post# of 10023
Even if your right about inmed having competition with their drug pipeline. IMO it doesn't matter. You can take their pipeline out of the equation! Their Biosynthesis and Bioinformatics tools are their money maker! Being able biosynthesis 90-100 cannabinoid's identically can't be understated. That alone will make this a multi billion dollar company!
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent INM News
More INM News